Kliniske studier for Lupus i Missouri
8 studier for Lupus søker deltakere på steder i Missouri.
Byer i Missouri
Offisiell studietekst (engelsk)
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
- Sl0044 50682, Kansas City
RekruttererFase 3
Alder 16 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06617325A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
- Research Site, Kansas City
RekruttererFase 3
Alder 18 til 70 · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07430306Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters
- Siteman Cancer Center at West County Hospital, Creve Coeur
- University Health Truman Medical Center, Kansas City
- og 6 flere
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 23. sep. 2026 · NCT03816345Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
- Research Site, St Louis
RekruttererFase 1
Alder 18 til 65 · Alle kjønn · Oppdatert 18. sep. 2026 · NCT07201558A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
- Research Site, St Louis
RekruttererFase 1/2
Alder 18 til 70 · Alle kjønn · Oppdatert 10. sep. 2026 · NCT06897930A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
- Washington University School of Medicine, St Louis
RekruttererFase 1
Alder 18 til 70 · Alle kjønn · Oppdatert 28. aug. 2026 · NCT06925542A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus
- Investigative Site, Saint Joseph
RekruttererFase 2
Alder 18 til 80 · Alle kjønn · Oppdatert 27. jul. 2026 · NCT07260877Lupus Landmark Study: A Prospective Registry and Biorepository
- Washington University, St Louis
RekruttererObservasjonsstudie
Alder 18 til 110 · Alle kjønn · Oppdatert 15. apr. 2026 · NCT05934149Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.